Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Becton Dickinson and Co (NYSE:BDX)

175.96
Delayed Data
As of 4:01pm ET
 +1.43 / +0.82%
Today’s Change
128.87
Today|||52-Week Range
177.50
+14.19%
Year-to-Date
No recent news for Becton Dickinson and Co.

Today’s Trading

Previous close174.53
Today’s open174.90
Day’s range173.98 - 176.17
Volume518,195
Average volume (3 months)889,584
Market cap$37.0B
Dividend yield1.50%
Data as of 4:01pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)-44.07%
Earnings growth (this year)+19.60%
Earnings growth (next 5 years)+11.25%
Revenue growth (last year)+21.94%
P/E ratio47.1
Price/Sales2.68
Price/Book5.13

Competitors

 Today’s
change
Today’s
% change
BSXBoston Scientific Co...+0.68+2.87%
SYKStryker Corp+0.13+0.11%
ZBHZimmer Biomet Holdin...+4.79+3.90%
EWEdwards Lifesciences...-1.45-1.27%
Data as of 4:01pm ET, 07/28/2016

Financials

Last reporting dateJuly 28, 2016
EPS forecast (this quarter)$2.21
Annual revenue (last year)$10.3B
Annual profit (last year)$695.0M
Net profit margin6.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Vincent A. Forlenza
EVP, Chief Financial &
Administrative Officer
Christopher R. Reidy
Corporate headquarters
Franklin Lakes, New Jersey

Forecasts

Partner Offers

Search for Jobs